BG108245A - Compositions containing imidazotriazinone for nasal application - Google Patents

Compositions containing imidazotriazinone for nasal application

Info

Publication number
BG108245A
BG108245A BG108245A BG10824503A BG108245A BG 108245 A BG108245 A BG 108245A BG 108245 A BG108245 A BG 108245A BG 10824503 A BG10824503 A BG 10824503A BG 108245 A BG108245 A BG 108245A
Authority
BG
Bulgaria
Prior art keywords
imidazotriazinone
compositions containing
nasal application
nasal
application
Prior art date
Application number
BG108245A
Other languages
Bulgarian (bg)
English (en)
Inventor
Peter Serno
Andreas Ohm
Wolfgang Barth
Richard-Josef Bauer
Hans-Martin Siefert
Dieter Zimmer
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG108245A publication Critical patent/BG108245A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG108245A 2001-04-12 2003-10-09 Compositions containing imidazotriazinone for nasal application BG108245A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10118306A DE10118306A1 (de) 2001-04-12 2001-04-12 Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation

Publications (1)

Publication Number Publication Date
BG108245A true BG108245A (en) 2005-01-31

Family

ID=7681379

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108245A BG108245A (en) 2001-04-12 2003-10-09 Compositions containing imidazotriazinone for nasal application

Country Status (25)

Country Link
US (2) US6740306B2 (xx)
EP (1) EP1381368A2 (xx)
JP (1) JP2004525968A (xx)
KR (1) KR20030087072A (xx)
CN (1) CN1537004A (xx)
AR (1) AR035821A1 (xx)
BG (1) BG108245A (xx)
BR (1) BR0208813A (xx)
CA (1) CA2443639A1 (xx)
CZ (1) CZ20032752A3 (xx)
DE (1) DE10118306A1 (xx)
DO (1) DOP2002000373A (xx)
EC (1) ECSP034795A (xx)
EE (1) EE200300501A (xx)
GT (1) GT200200070A (xx)
HU (1) HUP0303877A3 (xx)
IL (1) IL158255A0 (xx)
MX (1) MXPA03009314A (xx)
NO (1) NO20034556L (xx)
PE (1) PE20021035A1 (xx)
PL (1) PL363033A1 (xx)
RU (1) RU2003133143A (xx)
SK (1) SK12682003A3 (xx)
UY (1) UY27256A1 (xx)
WO (1) WO2002083674A2 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2449163C (en) * 2001-05-09 2010-07-13 Bayer Healthcare Ag New use of 2-phenyl-substituted imidazotriazinones
DE102004023069A1 (de) * 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
ZA200704869B (en) * 2004-12-23 2009-02-25 Roxro Pharma Inc Therapeutic compositions for intranasal administration of ketorolac
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
MX2008000087A (es) * 2005-06-23 2008-03-18 Schering Corp Formulaciones orales rapidamente absorbentes de inhibidores de la fosfodiesterasa 5.
KR20080056250A (ko) * 2005-09-29 2008-06-20 바이엘 헬스케어 아게 비뇨기 장애의 치료를 위한 ｐｄｅ 억제제 및 이들의 조합
CN101711153A (zh) * 2007-06-13 2010-05-19 拜耳先灵制药股份公司 用于治疗听觉损伤的pde抑制剂
AU2009257385A1 (en) * 2008-06-13 2009-12-17 Roxro Pharma, Inc. Pharmaceutical formulation of ketorolac for intranasal administration
US8277781B2 (en) * 2009-03-13 2012-10-02 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
US8551454B2 (en) * 2009-03-13 2013-10-08 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
WO2020006606A1 (en) * 2018-07-05 2020-01-09 Helium 3 Resources Pty Ltd A pharmaceutical composition and method of use of same
SE542968C2 (en) * 2018-10-26 2020-09-22 Lindahl Anders Treatment of osteoarthritis
BR112022024098A2 (pt) * 2020-05-26 2023-02-07 Strategic Drug Solutions Inc Formulações e métodos para tratar a disfunção erétil

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602099A (en) * 1973-04-02 1986-07-22 Merrell Dow Pharmaceuticals Inc. Antirhinovirus agents
GB9013750D0 (en) 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9301192D0 (en) 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
GB9514465D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
GB9514473D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
EP0985671B1 (en) 1996-05-31 2003-04-02 Mochida Pharmaceutical Co., Ltd. PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT
GB2315673A (en) * 1996-08-01 1998-02-11 Merck & Co Inc Treatment of migraine
WO1998053819A1 (fr) * 1997-05-29 1998-12-03 Mochida Pharmaceutical Co., Ltd. Agent therapeutique destine a traiter l'anerection
AU9214498A (en) 1997-09-23 1999-04-12 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
EP2295436A1 (de) 1997-11-12 2011-03-16 Bayer Schering Pharma AG 2-Phenyl-substituierte Imidazotriazinone als Phosphodiesterase V Inhibitoren
TWI223598B (en) * 1998-06-22 2004-11-11 Pfizer Ireland Pharmaceuticals An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate
WO2000000199A1 (en) * 1998-06-26 2000-01-06 Nastech Pharmaceutical Company, Inc. Nasal delivery of sildenafil citrate
HUP0104676A3 (en) * 1998-12-14 2005-12-28 Cellegy Pharmaceuticals Inc So Compositions for the treatment of anorectal disorders and their use

Also Published As

Publication number Publication date
RU2003133143A (ru) 2005-04-10
US20030022894A1 (en) 2003-01-30
WO2002083674A3 (de) 2003-01-09
IL158255A0 (en) 2004-05-12
NO20034556L (no) 2003-12-10
WO2002083674A2 (de) 2002-10-24
PE20021035A1 (es) 2002-11-29
ECSP034795A (es) 2003-12-01
PL363033A1 (en) 2004-11-15
CA2443639A1 (en) 2002-10-24
US20040248891A1 (en) 2004-12-09
CN1537004A (zh) 2004-10-13
DE10118306A1 (de) 2002-10-17
DOP2002000373A (es) 2002-11-30
NO20034556D0 (no) 2003-10-10
HUP0303877A2 (hu) 2004-03-29
MXPA03009314A (es) 2004-03-10
KR20030087072A (ko) 2003-11-12
HUP0303877A3 (en) 2005-05-30
EE200300501A (et) 2003-12-15
UY27256A1 (es) 2002-11-29
EP1381368A2 (de) 2004-01-21
GT200200070A (es) 2003-01-31
CZ20032752A3 (cs) 2004-01-14
US6740306B2 (en) 2004-05-25
JP2004525968A (ja) 2004-08-26
SK12682003A3 (sk) 2004-03-02
BR0208813A (pt) 2004-03-09
AR035821A1 (es) 2004-07-14

Similar Documents

Publication Publication Date Title
MXPA03009314A (es) Composiciones que contienen imidazotriazinona para administracion nasal.
TW200518771A (en) Formulations for coated microprojections containing non-volatile counterions
AP2001002204A0 (en) Pyrazole derivatives.
MXPA02012033A (es) Derivados de 2-aminocarbonil-9h-purina.
TNSN04141A1 (en) NEW COMPOUNDS - DDP - IV difluor
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
HUP0303886A3 (en) New film coating composition for coating of pharmaceutical compositions
GB0127903D0 (en) Improvements relating to organic compounds
AU2003228770A8 (en) Substituted pyrazolopyrimidines
TNSN07235A1 (en) Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
HK1071886A1 (en) Novel compounds and compositions as cathepsin inhibitors
MY126917A (en) Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
IL163777A0 (en) Kinase inhibitors
UA96759C2 (xx) ПОХІДНІ 2-АРИЛІНДОЛУ ЯК mPGES-1 ІНГІБІТОРИ$ПРОИЗВОДНЫЕ 2-АРИЛИНДОЛА КАК mPGES-1 ИНГИБИТОРЫ
MXPA04006266A (es) Pirimidotriazinas como inhibidores de fosfatasa.
BR0307595A (pt) Uso de inibidores de pde5 tal como sildenafil no tratamento de sìndrome de ovário policìstico
AU2002343661A1 (en) Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the teatment of cancer
MXPA04003755A (es) Endoprotesis vasculares.
CO5580729A2 (es) Composiciones nutricionales que comprenden cistationina
DE60201074D1 (en) Pyrazolopyridinderivate
WO2002083108A3 (de) Zusammensetzungen enthaltend cgmp-pde-inhibitoren und lokalanästhetika zur nasalen applikation
LT2003075A (en) Inhibitor of monoamine uptake
AU1142502A (en) Novel crystalline forms of a factor xa inhibitor
TW200603801A (en) Novel dialkoxy-imidazopyridines